Literature DB >> 17386912

Clinical predictors of mortality from infective endocarditis.

J Michael Smith1, Robert R So, Amy M Engel.   

Abstract

A cohort study with prospective data collection was conducted to determine which risk factors and outcome variables are statistically significant clinical predictors of mortality from infective endocarditis. A study was performed from an eleven-year, hospitalization cohort (N=11,230) in which the data were collected prospectively. The study examined 21 potential risk factors and 14 outcome variables. The risk factors were categorized into these various groups: patient factors, cardiac factors, co-morbidities, operative factors, infectious factors, and complications. The outcome variables were categorized into operative factors, infectious factors, and complications. Inclusion criteria included patients with endocarditis (N=87). Longer operative time, operative complications, and postoperative complications. Overall mortality was 11.5 percent (N=10). Endocarditis patients who died were significantly older (p=0.023) and had a longer pump time (p=0.017) than those who survived. Endocarditis patients who died were more likely to experience an unstable hemodynamic status (p=0.012). There was a significant difference between survival and non-survival of patients with endocarditis on nine outcome variables. They were more likely to require a re-operation for bleeding (p=0.034). Renal complications (p=0.016), neurological complications (p=0.004), pulmonary complications (p=0.001), intra-operative complications (p=0.035), and IAPB (p<0.001) were all more likely to occur in endocarditis patients who died. There are risk factors that serve as predictors of mortality from infectious endocarditis. These include age greater than 65 years, longer pump time, and unstable hemodynamic status. Outcome variables that reflected significant mortality included operative complications and post-operative complications. These factors may identify those patients with infective endocarditis eligible for more aggressive treatment.

Entities:  

Mesh:

Year:  2006        PMID: 17386912     DOI: 10.1016/j.ijsu.2006.06.008

Source DB:  PubMed          Journal:  Int J Surg        ISSN: 1743-9159            Impact factor:   6.071


  4 in total

1.  Brain MRI findings in neurologically asymptomatic patients with infective endocarditis.

Authors:  A Hess; I Klein; B Iung; P Lavallée; E Ilic-Habensus; Q Dornic; F Arnoult; L Mimoun; M Wolff; X Duval; J-P Laissy
Journal:  AJNR Am J Neuroradiol       Date:  2013-05-02       Impact factor: 3.825

2.  The need for a specific risk prediction system in native valve infective endocarditis surgery.

Authors:  Marisa De Feo; Maurizio Cotrufo; Antonio Carozza; Luca S De Santo; Francesco Amendolara; Salvatore Giordano; Ester E Della Ratta; Gianantonio Nappi; Alessandro Della Corte
Journal:  ScientificWorldJournal       Date:  2012-03-12

3.  Correlates of 90-Day Mortality Among People Who Do and Do Not Inject Drugs With Infective Endocarditis in Seattle, Washington.

Authors:  Maria A Corcorran; Jenell Stewart; Kristine Lan; Ayushi Gupta; Sara N Glick; Chetan Seshadri; Kevin J Koomalsingh; Edward F Gibbons; Robert D Harrington; Shireesha Dhanireddy; H Nina Kim
Journal:  Open Forum Infect Dis       Date:  2022-03-29       Impact factor: 4.423

4.  Comparison of the clinical features and outcomes of infective endocarditis between hemodialysis and non-hemodialysis patients.

Authors:  Ching-Chung Hsiao; Cheng-Hao Weng; Yi-Jung Li; Hsin-Hsu Wu; Yung-Chang Chen; Yu-Ming Chen; Hsiang-Hao Hsu; Ya-Chung Tian
Journal:  Ther Clin Risk Manag       Date:  2017-05-24       Impact factor: 2.423

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.